Literature DB >> 16620747

Identification and discrimination of extracellularly active cathepsins B and L in high-invasive melanoma cells.

Anke Klose1, Paola Zigrino, Ralf Dennhöfer, Cornelia Mauch, Nicolas Hunzelmann.   

Abstract

We established a novel protocol for lithium dodecyl sulfate (LDS) gelatin zymography, which operates under reducing conditions and at a slightly acidic pH value (6.5). This zymographic assay is based on polyacrylamide gel electrophoresis and facilitates the electrophoretic separation of human cathepsins in an active state. By this technique, activity of purified human liver cathepsin B was detected at a concentration as low as 50 ng and was blocked only in the presence of the cysteine protease inhibitor E-64 and the specific cathepsin B inhibitor CA-074 but not by aspartate, serine, or matrix metalloprotease inhibitors. The method was applied to analyze cathepsin activities in cell culture supernatants of the high-invasive melanoma cell line MV3. Interestingly, LDS zymography of MV3 cell supernatants in combination with specific inhibitors of cathepsins B and L identified three forms of extracellularly active cathepsin B and two forms of proteolytically active cathepsin L. We herein describe the generation and biochemical significance of acidic LDS zymography. This novel method permits not only the enzymatic analysis of purified cysteine proteases but also the identification and discrimination of different cathepsin activities in biological fluids, cell lysates, or supernatants, especially of cathepsins B and L, which are closely linked to major inflammatory and malignant processes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16620747     DOI: 10.1016/j.ab.2006.01.037

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  12 in total

1.  Cloning, expression, and characterization of an alternatively spliced variant of human heparanase.

Authors:  Nicola J Nasser; Aaron Avivi; Moran Shushy; Israel Vlodavsky; Eviatar Nevo
Journal:  Biochem Biophys Res Commun       Date:  2007-01-02       Impact factor: 3.575

2.  Secretome signature of invasive glioblastoma multiforme.

Authors:  Catherine A Formolo; Russell Williams; Heather Gordish-Dressman; Tobey J MacDonald; Norman H Lee; Yetrib Hathout
Journal:  J Proteome Res       Date:  2011-05-31       Impact factor: 4.466

3.  Oxygen-glucose deprivation (OGD) and interleukin-1 (IL-1) differentially modulate cathepsin B/L mediated generation of neuroprotective perlecan LG3 by neurons.

Authors:  Maxim G Saini; Gregory J Bix
Journal:  Brain Res       Date:  2011-12-20       Impact factor: 3.252

4.  Mechanism of Trypanosoma brucei gambiense resistance to human serum.

Authors:  Pierrick Uzureau; Sophie Uzureau; Laurence Lecordier; Frédéric Fontaine; Patricia Tebabi; Fabrice Homblé; Axelle Grélard; Vanessa Zhendre; Derek P Nolan; Laurence Lins; Jean-Marc Crowet; Annette Pays; Cécile Felu; Philippe Poelvoorde; Benoit Vanhollebeke; Soren K Moestrup; Jeppe Lyngsø; Jan Skov Pedersen; Jeremy C Mottram; Erick J Dufourc; David Pérez-Morga; Etienne Pays
Journal:  Nature       Date:  2013-08-21       Impact factor: 49.962

5.  Inhibition of cathepsin B activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  Mateusz Kędzior; Rafał Seredyński; Urszula Godzik; Dagmara Tomczyk; Jan Gutowicz; Ewa Terlecka; Ireneusz Całkosiński; Grzegorz Terlecki
Journal:  Environ Sci Pollut Res Int       Date:  2014-08-28       Impact factor: 4.223

Review 6.  Role of lysosomes in physiological activities, diseases, and therapy.

Authors:  Ziqi Zhang; Pengfei Yue; Tianqi Lu; Yang Wang; Yuquan Wei; Xiawei Wei
Journal:  J Hematol Oncol       Date:  2021-05-14       Impact factor: 17.388

7.  Cathepsin B inhibition interferes with metastatic potential of human melanoma: an in vitro and in vivo study.

Authors:  Paola Matarrese; Barbara Ascione; Laura Ciarlo; Rosa Vona; Carlo Leonetti; Marco Scarsella; Anna M Mileo; Caterina Catricalà; Marco G Paggi; Walter Malorni
Journal:  Mol Cancer       Date:  2010-08-04       Impact factor: 27.401

8.  Cystatin E/M suppresses legumain activity and invasion of human melanoma.

Authors:  Jon J Briggs; Mads H Haugen; Harald T Johansen; Adam I Riker; Magnus Abrahamson; Øystein Fodstad; Gunhild M Maelandsmo; Rigmor Solberg
Journal:  BMC Cancer       Date:  2010-01-15       Impact factor: 4.430

9.  The functional expression and characterisation of a cysteine peptidase from the invasive stage of the neuropathogenic schistosome Trichobilharzia regenti.

Authors:  Katerina Dolecková; Martin Kasný; Libor Mikes; Jared Cartwright; Petr Jedelský; Eric L Schneider; Jan Dvorák; Adrian P Mountford; Charles S Craik; Petr Horák
Journal:  Int J Parasitol       Date:  2008-07-26       Impact factor: 3.981

10.  Characterization of thimet oligopeptidase and neurolysin activities in B16F10-Nex2 tumor cells and their involvement in angiogenesis and tumor growth.

Authors:  Thaysa Paschoalin; Adriana K Carmona; Elaine G Rodrigues; Vitor Oliveira; Hugo P Monteiro; Maria A Juliano; Luiz Juliano; Luiz R Travassos
Journal:  Mol Cancer       Date:  2007-07-09       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.